Market revenue in 2023 | USD 85.7 million |
Market revenue in 2030 | USD 112.2 million |
Growth rate | 3.9% (CAGR from 2023 to 2030) |
Largest segment | Powder |
Fastest growing segment | Liquid |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Powder, Liquid |
Key market players worldwide | Merck KGaA, Qiagen NV, Thermo Fisher Scientific Inc, Roche Holding AG ADR, Abcam PLC, Agilent Technologies Inc, Codexis Inc, Promega, Takara Bio Inc, New England Biolabs, MP Biomedicals, Minerva Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to proteinase k market will help companies and investors design strategic landscapes.
Powder was the largest segment with a revenue share of 52.51% in 2023. Horizon Databook has segmented the Middle East & Africa proteinase k market based on powder, liquid covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa proteinase k market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa proteinase k market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account